A detailed history of Quest Partners LLC transactions in Pulmonx Corp stock. As of the latest transaction made, Quest Partners LLC holds 2,634 shares of LUNG stock, worth $17,884. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,634
Holding current value
$17,884
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$5.59 - $8.58 $14,724 - $22,599
2,634 New
2,634 $21.8 Million
Q1 2024

May 09, 2024

SELL
$8.71 - $14.65 $8,265 - $13,902
-949 Reduced 12.91%
6,403 $59.4 Million
Q4 2023

Feb 09, 2024

BUY
$7.89 - $13.14 $58,007 - $96,605
7,352 New
7,352 $93.7 Million

Others Institutions Holding LUNG

About Pulmonx Corp


  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $253M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.